Current Evidence Does Not Support Substantial DNA Cytosine Methylation in Myxosporean Genomes
Genome Biology and Evolution · 04.11.2026
DOI: 10.1093/gbe/evag279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome Biology and Evolution, online erschienen am 04.11.2026. Verfasst von Dorothée Huchon und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Zoology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 6997801, Israel. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Some invertebrate lineages are known to have lost their ability to methylate DNA cytosines. These lineages have often lost the enzymes responsible for cytosine methylation (DNMT1 and 3), as well as other enzymes that interact with methylated cytosines. Previous studies showed that myxosporeans, a group of parasitic cnidarians, lack recognisable DNMTs and other canonical methylation enzymes, and observed a lack of cytosine methylation in two myxosporeans using whole genome bisulfite sequencing. Recently, a study of five myxosporean samples using Oxford Nanopore Technologies (ONT) sequencing reported high levels of methylation in two samples and low levels in the others and the presence of methylation-related genes in their assemblies. Here, we provide evidence that the two assemblies for which high levels of methylation were reported are heavily contaminated with fish-host sequences. In the other three samples, the lower apparent methylation signal resembles that observed in unmethylated negative controls and can be explained by ONT-background noise. Moreover, the CpG observed-to-expected ratios of the five assemblies differ from those of well-curated myxosporean assemblies. Additionally, the reported methylation profiles do not exhibit the typical distribution seen in invertebrates, possibly reflecting the presence of host contaminants. Finally, we found that most of the genes analysed are not canonical components of cytosine methylation pathways, and that the few candidate methylation-related genes reported in myxosporeans are more consistent with bacterial contamination than with genuine myxosporean genes. Together, these observations underscore important caveats in inferring the presence or absence of cytosine methylation in parasite genomes, particularly when using emerging technologies, and suggest that there is currently no robust evidence for substantial cytosine methylation in myxosporeans.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Zoology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
- The Steinhardt Museum of Natural History and National Research Center, Tel Aviv University, Tel Aviv, 6997801, Israel.
- Department of Ecology and Evolution and Marine Biology, University of California, Santa Barbara, CA, USA.
- Neuroscience Research Institute, University of California, Santa Barbara, CA, USA.
- Biology Department, University of Nevada, Reno, NV, USA.
- Department of Molecular Cell Biology, Faculty of Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
ORCID-Profile: Dorothée Huchon, Dongmin R Son, Soojin V Yi, David Alvarez-Ponce
Zitieren
APA
Huchon, D., Son, D. R., Protic, I. A., Sandberg, T. O. M., Yi, S. V., & Alvarez-Ponce, D. (2026). Current Evidence Does Not Support Substantial DNA Cytosine Methylation in Myxosporean Genomes. Genome Biology and Evolution. https://doi.org/10.1093/gbe/evag279
Vancouver
Huchon D, Son DR, Protic IA, Sandberg TOM, Yi SV, Alvarez-Ponce D. Current Evidence Does Not Support Substantial DNA Cytosine Methylation in Myxosporean Genomes. Genome Biology and Evolution. 2026. doi:10.1093/gbe/evag279
BibTeX
@article{Huchon2026,
author = {Huchon, Dorothée and Son, Dongmin R and Protic, Ismam Ahmed and Sandberg, Tatiana Orli Milkewitz and Yi, Soojin V and Alvarez-Ponce, David},
title = {Current Evidence Does Not Support Substantial DNA Cytosine Methylation in Myxosporean Genomes},
journal = {Genome Biology and Evolution},
year = {2026},
doi = {10.1093/gbe/evag279}
}
EUVIMED